Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

75.2K
Overview
75.2K
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

12.0K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
12.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Epilepsy ll: Types01:22

Epilepsy ll: Types

47
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demyelination-induced glutamatergic imbalance mediates hippocampal Hyperexcitability.

Neurobiology of disease·2025
Same author

FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions.

Frontiers in neuroscience·2025
Same author

Cortical layer-specific abnormalities in auditory responses in a mouse model of Fragile X Syndrome.

Neurobiology of disease·2025
Same author

Developmental trajectory and sex differences in auditory processing in a PTEN-deletion model of autism spectrum disorders.

Neurobiology of disease·2024
Same author

Post Deep Brain Stimulation Time Course of Aperiodic Activity in Childhood and Young Adult Dystonia.

Movement disorders clinical practice·2024
Same author

Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice.

Neurobiology of disease·2024
Same journal

Preface.

Handbook of clinical neurology·2026
Same journal

Foreword.

Handbook of clinical neurology·2026
Same journal

Fundus autofluorescence imaging.

Handbook of clinical neurology·2026
Same journal

The electroretinogram as a means to study the physiology of the retina.

Handbook of clinical neurology·2026
Same journal

Adaptive optics scanning light ophthalmoscopy.

Handbook of clinical neurology·2026
Same journal

Modeling the human retina in a dish: Advances and future directions.

Handbook of clinical neurology·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

16.6K

Neuroglia in epilepsy.

Manolia R Ghouli1, Devin K Binder1

  • 1Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, CA, United States; Center for Glial-Neuronal Interactions, University of California, Riverside, Riverside, CA, United States.

Handbook of Clinical Neurology
|March 27, 2025
PubMed
Summary
This summary is machine-generated.

Exploring novel epilepsy treatments, this research highlights glia as key targets beyond neurons. Targeting glial cells offers new hope for effective antiseizure drugs (ASDs) with fewer side effects.

Keywords:
AstrogliaBlood–brain barrierEpilepsyGliaMicrogliaOligodendroglia

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.0K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.3K

Related Experiment Videos

Last Updated: May 5, 2026

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
10:24

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Published on: May 15, 2018

16.6K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.0K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.3K

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Epilepsy is a neurological disorder marked by recurrent seizures due to abnormal neuronal activity.
  • Current antiseizure drugs (ASDs) primarily target neuronal pathways, offering limited efficacy for about 30% of patients and causing cognitive side effects.
  • Glia, once considered mere support cells, are now recognized as crucial modulators of neuronal function in both health and disease.

Purpose of the Study:

  • To explore the role of glial cells (astroglia, oligodendroglia, microglia) in epilepsy.
  • To identify novel non-neuronal therapeutic targets for developing new antiseizure drugs (ASDs).
  • To address the limitations of current ASDs, including treatment resistance and adverse cognitive effects.

Main Methods:

  • Review of current literature on glial cell involvement in epilepsy.
  • Analysis of glial contributions to seizure genesis, development, and progression.
  • Identification of specific glial enzymes, receptors, transporters, and channels as potential therapeutic targets.

Main Results:

  • Glia play significant roles in the pathophysiology of epilepsy.
  • Specific glial targets offer potential for novel antiseizure drug development.
  • Targeting glia may lead to ASDs with improved efficacy and reduced side effects compared to current neuronal-targeting drugs.

Conclusions:

  • Glia represent a promising avenue for developing next-generation antiseizure therapies.
  • Focusing on non-neuronal targets like glia could overcome limitations of existing treatments for refractory epilepsy.
  • Further research into glial mechanisms is essential for translating these findings into clinical applications.